Screener
Summit Therapeutics SMMT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 19,398 | 20,616 |
| Goodwill | 1,965 | 2,001 |
| Other assets | 8,231 | 7,205 |
| Total assets | $647,856 | $751,182 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $27,549 | $20,292 |
| Accrued liabilities | 44,317 | 32,100 |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's total assets?
- Summit Therapeutics (SMMT) reported total assets of $647.86M in Q1 2026.
- How has Summit Therapeutics's total assets changed year-over-year?
- Summit Therapeutics's total assets increased by 68.8% year-over-year, from $383.82M to $647.86M.
- What is the long-term trend for Summit Therapeutics's total assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's total assets has grown at a 48.9% compound annual growth rate (CAGR), from $102.5M to $751.18M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Summit Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude